Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

Updates
DoVE Return on Investment (ROI) Publication Launch
August 2020

The Decade of Vaccine Economics (DoVE) Project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment for vaccines preventing 10 infectious diseases in 73 countries that have received support from Gavi, the Vaccine Alliance.

Read More >
Joint Statement on COVID-19 Vaccines & Older Adults
July 2020

As WHO, CEPI, and Gavi meet and consider how best to manage the planning and deployment of a COVID-19 vaccine, we feel the voice of older adults, one of the most vulnerable, important, and essential groups should feature prominently in the COVAX process. In keeping with COVAX’s stated goal of equity, we recommend: Prioritizing development […]

Read More >
Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

[Where We Work - Map]